Class information for:
Level 1: TIGECYCLINE//GLYCYLCYCLINE//GLYCYLCYCLINES

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16583 581 29.0 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
361 16717 ACINETOBACTER BAUMANNII//ESBL//EXTENDED SPECTRUM BETA LACTAMASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TIGECYCLINE Author keyword 165 50% 41% 236
2 GLYCYLCYCLINE Author keyword 30 64% 5% 29
3 GLYCYLCYCLINES Author keyword 20 53% 5% 27
4 GAR 936 Author keyword 13 71% 2% 10
5 BROAD SPECTRUM ANTIBACTERIAL THERAPY Author keyword 11 100% 1% 6
6 WERNER FORSSMANN HOSP Address 11 100% 1% 6
7 CLIN INTERNAL INTENS MED INTERDISCIPLINARY EMER Address 8 100% 1% 5
8 NORTH HOSP AMIENS Address 8 100% 1% 5
9 GLYCYLCYCLINE ANTIBIOTICS Author keyword 6 80% 1% 4
10 KAOHSIUNG MED INFECT DIS Address 6 80% 1% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TIGECYCLINE 165 50% 41% 236 Search TIGECYCLINE Search TIGECYCLINE
2 GLYCYLCYCLINE 30 64% 5% 29 Search GLYCYLCYCLINE Search GLYCYLCYCLINE
3 GLYCYLCYCLINES 20 53% 5% 27 Search GLYCYLCYCLINES Search GLYCYLCYCLINES
4 GAR 936 13 71% 2% 10 Search GAR+936 Search GAR+936
5 BROAD SPECTRUM ANTIBACTERIAL THERAPY 11 100% 1% 6 Search BROAD+SPECTRUM+ANTIBACTERIAL+THERAPY Search BROAD+SPECTRUM+ANTIBACTERIAL+THERAPY
6 GLYCYLCYCLINE ANTIBIOTICS 6 80% 1% 4 Search GLYCYLCYCLINE+ANTIBIOTICS Search GLYCYLCYCLINE+ANTIBIOTICS
7 NON INTERVENTIONAL STUDIES 4 56% 1% 5 Search NON+INTERVENTIONAL+STUDIES Search NON+INTERVENTIONAL+STUDIES
8 BONE ASSAY 3 100% 1% 3 Search BONE+ASSAY Search BONE+ASSAY
9 COMPLICATED INTRA ABDOMINAL INFECTIONS 2 36% 1% 5 Search COMPLICATED+INTRA+ABDOMINAL+INFECTIONS Search COMPLICATED+INTRA+ABDOMINAL+INFECTIONS
10 COMPLICATED INFECTIONS 2 67% 0% 2 Search COMPLICATED+INFECTIONS Search COMPLICATED+INFECTIONS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GAR 936 201 78% 23% 131
2 GLYCYLCYCLINE 186 83% 18% 104
3 REDUCING REAGENT OXYRASE 45 94% 3% 16
4 GLYCYLCYCLINES 41 68% 6% 36
5 EXPOSURE RESPONSE ANALYSES 31 74% 4% 23
6 TRIAL TEST PROGRAM 31 82% 3% 18
7 COMPLICATED INTRAABDOMINAL INFECTIONS 29 38% 10% 61
8 SURVEILLANCE TRIAL 21 78% 2% 14
9 VANCOMYCIN AZTREONAM 21 71% 3% 17
10 GLYCYLCYCLINE ANTIMICROBIAL AGENT 21 85% 2% 11

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Efficacy and safety of tigecycline: a systematic review and meta-analysis 2011 87 42 88%
Tigecycline: a critical safety review 2015 1 35 83%
Tigecycline: an update 2013 22 49 78%
Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis 2015 3 38 32%
Tigecycline: A critical analysis 2006 134 24 88%
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies 2008 75 73 73%
A review of tigecycline - the first glycylcycline 2008 52 27 70%
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence 2008 82 75 49%
Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections 2014 6 25 56%
The emergence of clinical resistance to tigecycline 2013 20 71 38%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 WERNER FORSSMANN HOSP 11 100% 1.0% 6
2 CLIN INTERNAL INTENS MED INTERDISCIPLINARY EMER 8 100% 0.9% 5
3 NORTH HOSP AMIENS 8 100% 0.9% 5
4 KAOHSIUNG MED INFECT DIS 6 80% 0.7% 4
5 INFECT DIS DISCOVERY 4 46% 1.0% 6
6 PROC CHEM RD 3 50% 0.7% 4
7 ANTIINFECT INTELLIGENCE GMBH 1 50% 0.3% 2
8 FIDSA 1 33% 0.3% 2
9 CLIN ENDOSCOP SURG 1 50% 0.2% 1
10 COEUR DEF TOUR A 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000163034 ACINETOBACTER BAUMANNII//ACINETOBACTER//A BAUMANNII
2 0.0000142262 DAPTOMYCIN//TELAVANCIN//HVISA
3 0.0000136655 CARBAPENEMASE//OXA 48//KPC
4 0.0000135590 COLISTIN//POLYMYXINS//COLISTIMETHATE SODIUM
5 0.0000123155 TETRACYCLINE H ANTIPORTER//TET REPRESSOR//LEHRSTUHL MIKROBIOL BIOCHEM GENET
6 0.0000117012 CEFTAROLINE//CEFTOBIPROLE//CEFTOLOZANE TAZOBACTAM
7 0.0000085965 LINEZOLID//OXAZOLIDINONE//LINEZOLID RESISTANCE
8 0.0000069629 TERTIARY PERITONITIS//MANNHEIM PERITONITIS INDEX//SECONDARY PERITONITIS
9 0.0000062351 BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV
10 0.0000049720 MULTIDRUG EFFLUX PUMP//EFFLUX PUMP//EFFLUX PUMP INHIBITOR